-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 EcCZDjkLfmgoz8BxE09+CFvkvY5DvmKaikj3y+AJ5MrRPRxzX3ujcsoyPFs780su
 YYXf33rxEvt2RBo0p8HQCw==

<SEC-DOCUMENT>0001125282-04-001796.txt : 20040428
<SEC-HEADER>0001125282-04-001796.hdr.sgml : 20040428
<ACCEPTANCE-DATETIME>20040428153955
ACCESSION NUMBER:		0001125282-04-001796
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20040428
FILED AS OF DATE:		20040428

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			JPMP GLOBAL INVESTORS L P
		CENTRAL INDEX KEY:			0001281161
		STATE OF INCORPORATION:			DE

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-50680
		FILM NUMBER:		04760510

	MAIL ADDRESS:	
		STREET 1:		1221 AVENUE OF THE AMERICAS
		STREET 2:		40TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10021

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BARRIER THERAPEUTICS INC
		CENTRAL INDEX KEY:			0001173657
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				223828030
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		600 COLLEGE ROAD EAST
		STREET 2:		SUITE 3200
		CITY:			PRINCETON
		STATE:			NJ
		ZIP:			08540
		BUSINESS PHONE:		6099451200

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			JP MORGAN PARTNERS GLOBAL INVESTORS LP
		CENTRAL INDEX KEY:			0001162622
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-50680
		FILM NUMBER:		04760514

	BUSINESS ADDRESS:	
		STREET 1:		1221 AVENUE OF THE AMERICAS
		STREET 2:		40TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10020
		BUSINESS PHONE:		212-899-3689

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			J P MORGAN PARTNERS GLOBAL INVESTORS A LP
		CENTRAL INDEX KEY:			0001167095
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-50680
		FILM NUMBER:		04760512

	BUSINESS ADDRESS:	
		STREET 1:		1221 AVENUE OF THE AMERICAS
		STREET 2:		40TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10020
		BUSINESS PHONE:		212 899 3689

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			J P MORGAN CHASE & CO
		CENTRAL INDEX KEY:			0000019617
		STANDARD INDUSTRIAL CLASSIFICATION:	NATIONAL COMMERCIAL BANKS [6021]
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-50680
		FILM NUMBER:		04760515

	BUSINESS ADDRESS:	
		STREET 1:		270 PARK AVE
		STREET 2:		39TH FL
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10017
		BUSINESS PHONE:		2122706000

	MAIL ADDRESS:	
		STREET 1:		270 PARK AVENUE
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10017

	FORMER NAME:	
		FORMER CONFORMED NAME:	CHASE MANHATTAN CORP /DE/
		DATE OF NAME CHANGE:	19960402

	FORMER NAME:	
		FORMER CONFORMED NAME:	CHEMICAL BANKING CORP
		DATE OF NAME CHANGE:	19920703

	FORMER NAME:	
		FORMER CONFORMED NAME:	CHEMICAL NEW YORK CORP
		DATE OF NAME CHANGE:	19880508

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			JP MORGAN PARTNERS BHCA LP
		CENTRAL INDEX KEY:			0001106607
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-50680
		FILM NUMBER:		04760518

	BUSINESS ADDRESS:	
		STREET 1:		J.P. MORGAN PARTNERS
		STREET 2:		1221 AVENUE OF THE AMERICAS 40TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10020
		BUSINESS PHONE:		2128993400

	MAIL ADDRESS:	
		STREET 1:		J.P. MORGAN PARTNERS
		STREET 2:		1221 AVENUE OF THE AMERICAS 40TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10020

	FORMER NAME:	
		FORMER CONFORMED NAME:	CHASE EQUITY ASSOCIATES LLC
		DATE OF NAME CHANGE:	20000214

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			J P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN II LP
		CENTRAL INDEX KEY:			0001169889
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-50680
		FILM NUMBER:		04760511

	BUSINESS ADDRESS:	
		STREET 1:		C/O J P MORGAN PARTNERS
		STREET 2:		1221 AVENUE OF THE AMERICAS 40TH FL
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10020
		BUSINESS PHONE:		2128993400

	MAIL ADDRESS:	
		STREET 1:		C/O J P MORGAN PARTNERS
		STREET 2:		1221 AVENUE OF THE AMERICAS 40TH FL
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10020

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			J P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN LP
		CENTRAL INDEX KEY:			0001169890
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-50680
		FILM NUMBER:		04760513

	BUSINESS ADDRESS:	
		STREET 1:		C/O J P MORGAN PARTNERS
		STREET 2:		1221 AVENUE OF THE AMERICAS 40TH FL
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10020
		BUSINESS PHONE:		2128993400

	MAIL ADDRESS:	
		STREET 1:		C/O J P MORGAN PARTNERS
		STREET 2:		1221 AVENUE OF THE AMERICAS 40TH FL
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10020

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			JPMP MASTER FUND MANAGER L P
		CENTRAL INDEX KEY:			0001243235
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-50680
		FILM NUMBER:		04760517

	BUSINESS ADDRESS:	
		STREET 1:		JP MORGAN PARTNERS LLC
		STREET 2:		1221 AVENUE OF THE AMERICAS 40TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10020
		BUSINESS PHONE:		212 899-3400

	MAIL ADDRESS:	
		STREET 1:		C/O JPMORGAN PARTNERS LLC
		STREET 2:		1221 AVENUE OF THE AMERICAS 40TH FL.
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10020

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			JPMP CAPITAL CORP
		CENTRAL INDEX KEY:			0001243236
		STATE OF INCORPORATION:			NY
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-50680
		FILM NUMBER:		04760516

	BUSINESS ADDRESS:	
		STREET 1:		C/O J.P. MORGAN PARTNERS, LLC
		STREET 2:		1221 AVENUE OF THE AMERICAS 40TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10020
		BUSINESS PHONE:		212 899-3400

	MAIL ADDRESS:	
		STREET 1:		C/O JPMORGAN PARTNERS
		STREET 2:		1221 AVENUE OF THE AMERICAS 40TH FL.
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10020

	FORMER NAME:	
		FORMER CONFORMED NAME:	JPMP CAPITAL LLC
		DATE OF NAME CHANGE:	20030618
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>b331611_ex.xml
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0202</schemaVersion>

    <documentType>3</documentType>

    <periodOfReport>2004-04-28</periodOfReport>

    <noSecuritiesOwned>0</noSecuritiesOwned>

    <issuer>
        <issuerCik>0001173657</issuerCik>
        <issuerName>BARRIER THERAPEUTICS INC</issuerName>
        <issuerTradingSymbol>BTRX</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001106607</rptOwnerCik>
            <rptOwnerName>JP MORGAN PARTNERS BHCA LP</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O J.P. MORGAN PARTNERS</rptOwnerStreet1>
            <rptOwnerStreet2>1221 AVENUE OF THE AMERICAS 40TH FLOOR</rptOwnerStreet2>
            <rptOwnerCity>NEW YORK</rptOwnerCity>
            <rptOwnerState>NY</rptOwnerState>
            <rptOwnerZipCode>10020</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001243235</rptOwnerCik>
            <rptOwnerName>JPMP MASTER FUND MANAGER L P</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O JP MORGAN PARTNERS LLC</rptOwnerStreet1>
            <rptOwnerStreet2>1221 AVENUE OF THE AMERICAS 40TH FLOOR</rptOwnerStreet2>
            <rptOwnerCity>NEW YORK</rptOwnerCity>
            <rptOwnerState>NY</rptOwnerState>
            <rptOwnerZipCode>10020</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001243236</rptOwnerCik>
            <rptOwnerName>JPMP CAPITAL CORP</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O J.P. MORGAN PARTNERS, LLC</rptOwnerStreet1>
            <rptOwnerStreet2>1221 AVENUE OF THE AMERICAS 40TH FLOOR</rptOwnerStreet2>
            <rptOwnerCity>NEW YORK</rptOwnerCity>
            <rptOwnerState>NY</rptOwnerState>
            <rptOwnerZipCode>10020</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0000019617</rptOwnerCik>
            <rptOwnerName>J P MORGAN CHASE &amp; CO</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>270 PARK AVE</rptOwnerStreet1>
            <rptOwnerStreet2>39TH FL</rptOwnerStreet2>
            <rptOwnerCity>NEW YORK</rptOwnerCity>
            <rptOwnerState>NY</rptOwnerState>
            <rptOwnerZipCode>10017</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001162622</rptOwnerCik>
            <rptOwnerName>JP MORGAN PARTNERS GLOBAL INVESTORS LP</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O J.P. MORGAN PARTNERS, LLC</rptOwnerStreet1>
            <rptOwnerStreet2>1221 AVENUE OF THE AMERICAS 40TH FLOOR</rptOwnerStreet2>
            <rptOwnerCity>NEW YORK</rptOwnerCity>
            <rptOwnerState>NY</rptOwnerState>
            <rptOwnerZipCode>10020</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001169890</rptOwnerCik>
            <rptOwnerName>J P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN LP</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O J P MORGAN PARTNERS</rptOwnerStreet1>
            <rptOwnerStreet2>1221 AVENUE OF THE AMERICAS 40TH FL</rptOwnerStreet2>
            <rptOwnerCity>NEW YORK</rptOwnerCity>
            <rptOwnerState>NY</rptOwnerState>
            <rptOwnerZipCode>10020</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001167095</rptOwnerCik>
            <rptOwnerName>J P MORGAN PARTNERS GLOBAL INVESTORS A LP</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>1221 AVENUE OF THE AMERICAS</rptOwnerStreet1>
            <rptOwnerStreet2>40TH FLOOR</rptOwnerStreet2>
            <rptOwnerCity>NEW YORK</rptOwnerCity>
            <rptOwnerState>NY</rptOwnerState>
            <rptOwnerZipCode>10020</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001169889</rptOwnerCik>
            <rptOwnerName>J P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN II LP</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O J P MORGAN PARTNERS</rptOwnerStreet1>
            <rptOwnerStreet2>1221 AVENUE OF THE AMERICAS 40TH FL</rptOwnerStreet2>
            <rptOwnerCity>NEW YORK</rptOwnerCity>
            <rptOwnerState>NY</rptOwnerState>
            <rptOwnerZipCode>10020</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001281161</rptOwnerCik>
            <rptOwnerName>JPMP GLOBAL INVESTORS L P</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>1221 AVENUE OF THE AMERICAS</rptOwnerStreet1>
            <rptOwnerStreet2>40TH FLOOR</rptOwnerStreet2>
            <rptOwnerCity>NEW YORK</rptOwnerCity>
            <rptOwnerState>NY</rptOwnerState>
            <rptOwnerZipCode>10021</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <derivativeTable>
        <derivativeHolding>
            <securityTitle>
                <value>Series B Convertible Preferred Stock</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <footnoteId id="F2"/>
            </conversionOrExercisePrice>
            <exerciseDate>
                <footnoteId id="F1"/>
            </exerciseDate>
            <expirationDate>
                <footnoteId id="F1"/>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>4201280.000</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
        <derivativeHolding>
            <securityTitle>
                <value>Series B Convertible Preferred Stock</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <footnoteId id="F2"/>
            </conversionOrExercisePrice>
            <exerciseDate>
                <footnoteId id="F1"/>
            </exerciseDate>
            <expirationDate>
                <footnoteId id="F1"/>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>665744.000</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>I</value>
                </directOrIndirectOwnership>
                <natureOfOwnership>
                    <value>See Footnote</value>
                    <footnoteId id="F3"/>
                </natureOfOwnership>
            </ownershipNature>
        </derivativeHolding>
        <derivativeHolding>
            <securityTitle>
                <value>Series B Convertible Preferred Stock</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <footnoteId id="F2"/>
            </conversionOrExercisePrice>
            <exerciseDate>
                <footnoteId id="F1"/>
            </exerciseDate>
            <expirationDate>
                <footnoteId id="F1"/>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>337900.0000</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>I</value>
                </directOrIndirectOwnership>
                <natureOfOwnership>
                    <value>See Footnote</value>
                    <footnoteId id="F4"/>
                </natureOfOwnership>
            </ownershipNature>
        </derivativeHolding>
        <derivativeHolding>
            <securityTitle>
                <value>Series B Convertible Preferred Stock</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <footnoteId id="F2"/>
            </conversionOrExercisePrice>
            <exerciseDate>
                <footnoteId id="F1"/>
            </exerciseDate>
            <expirationDate>
                <footnoteId id="F1"/>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>90754.0000</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>I</value>
                </directOrIndirectOwnership>
                <natureOfOwnership>
                    <value>See Footnote</value>
                    <footnoteId id="F5"/>
                </natureOfOwnership>
            </ownershipNature>
        </derivativeHolding>
        <derivativeHolding>
            <securityTitle>
                <value>Series B Convertible Preferred Stock</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <footnoteId id="F2"/>
            </conversionOrExercisePrice>
            <exerciseDate>
                <footnoteId id="F1"/>
            </exerciseDate>
            <expirationDate>
                <footnoteId id="F1"/>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>37657.0000</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>I</value>
                </directOrIndirectOwnership>
                <natureOfOwnership>
                    <value>See Footnote</value>
                    <footnoteId id="F6"/>
                </natureOfOwnership>
            </ownershipNature>
        </derivativeHolding>
        <derivativeHolding>
            <securityTitle>
                <value>Series C Convertible Preferred Stock</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <footnoteId id="F2"/>
            </conversionOrExercisePrice>
            <exerciseDate>
                <footnoteId id="F1"/>
            </exerciseDate>
            <expirationDate>
                <footnoteId id="F1"/>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>740321.0000</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
        <derivativeHolding>
            <securityTitle>
                <value>Series C Convertible Preferred Stock</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <footnoteId id="F2"/>
            </conversionOrExercisePrice>
            <exerciseDate>
                <footnoteId id="F1"/>
            </exerciseDate>
            <expirationDate>
                <footnoteId id="F1"/>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>130207.0000</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>I</value>
                </directOrIndirectOwnership>
                <natureOfOwnership>
                    <value>See Footnote</value>
                    <footnoteId id="F3"/>
                </natureOfOwnership>
            </ownershipNature>
        </derivativeHolding>
        <derivativeHolding>
            <securityTitle>
                <value>Series C Convertible Preferred Stock</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <footnoteId id="F2"/>
            </conversionOrExercisePrice>
            <exerciseDate>
                <footnoteId id="F1"/>
            </exerciseDate>
            <expirationDate>
                <footnoteId id="F1"/>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>65370.0000</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>I</value>
                </directOrIndirectOwnership>
                <natureOfOwnership>
                    <value>See Footnote</value>
                    <footnoteId id="F4"/>
                </natureOfOwnership>
            </ownershipNature>
        </derivativeHolding>
        <derivativeHolding>
            <securityTitle>
                <value>Series C Convertible Preferred Stock</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <footnoteId id="F2"/>
            </conversionOrExercisePrice>
            <exerciseDate>
                <footnoteId id="F1"/>
            </exerciseDate>
            <expirationDate>
                <footnoteId id="F1"/>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>20007.0000</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>I</value>
                </directOrIndirectOwnership>
                <natureOfOwnership>
                    <value>See Footnote</value>
                    <footnoteId id="F5"/>
                </natureOfOwnership>
            </ownershipNature>
        </derivativeHolding>
        <derivativeHolding>
            <securityTitle>
                <value>Series C Convertible Preferred Stock</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <footnoteId id="F2"/>
            </conversionOrExercisePrice>
            <exerciseDate>
                <footnoteId id="F1"/>
            </exerciseDate>
            <expirationDate>
                <footnoteId id="F1"/>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>7310.0000</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>I</value>
                </directOrIndirectOwnership>
                <natureOfOwnership>
                    <value>See Footnote</value>
                    <footnoteId id="F6"/>
                </natureOfOwnership>
            </ownershipNature>
        </derivativeHolding>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">All of the outstanding shares of the Issuer's Series B Convertible Preferred Stock and Series C Convertible Preferred Stock will convert automatically on a 2 for 1 basis into Common Stock of the Company prior to the Issuer's initial public offering.</footnote>
        <footnote id="F2">These shares are convertible on a 2 for 1 basis.</footnote>
        <footnote id="F3">The amount shown represents the beneficial ownership of the Issuer's equity securities by J.P. Morgan Partners Global Investors, L.P.</footnote>
        <footnote id="F4">The amount shown represents the beneficial ownership of the Issuer's equity securities by J.P. Morgan Partners Global Investors (Cayman), L.P.</footnote>
        <footnote id="F5">The amount shown represents the beneficial ownership of the Issuer's equity securities by J.P. Morgan Partners Global Investors A, L.P.</footnote>
        <footnote id="F6">The amount shown represents the beneficial ownership of the Issuer's equity securities by J.P. Morgan Partners Global Investors (Cayman) II, L.P.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>Damion Wicker M.D.</signatureName>
        <signatureDate>2004-04-27</signatureDate>
    </ownerSignature>
</ownershipDocument>

</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>b331611_ex99-1.htm
<DESCRIPTION>EX 99-1
<TEXT>
<html>
<head><title>
Prepared and filed by St Ives Burrups
</title>
</head>
<body bgcolor="#FFFFFF">
<p align="right">&nbsp;</p>
<p align="right"><font size="2" face="serif"><b>Exhibit
      99.1</b></font></p>
<table width="100%" border="1" cellpadding="4" cellspacing="0" bordercolor="#000000">
<tr valign="bottom">
<td width="18%" align="center"><font size="2" face="serif"><b>Name and <br>
  Address of <br>
  Reporting Person<sup>(1)</sup></b></font></td>
<td width="10%"><div align="center"><font size="2" face="serif"><b>Designated Reporter<sup>(1)</sup></b></font></div></td>
<td width="8%" align="center"><font size="2" face="serif"><b>Date of Event Requiring
    Statement</b></font></td>
<td width="12%" align="center"><font size="2" face="serif"><b>Issuer Name, Ticker</b></font><br>
  <font size="2" face="serif"><b>or Trading Symbol</b></font></td>
<td width="9%"><div align="center"><font size="2" face="serif"><b>Title and Amount of <br>
  Security</b></font>
</div></td>
<td width="12%" align="center"><font size="2" face="serif"><b>Title of Derivative
    Securities and Title and Amount of Securities Underlying Derivative Securities</b></font></td>
<td width="9%" align="center"><font size="2" face="serif"><b>Ownership Form:</b></font> <font size="2" face="serif"><b>Direct
      (D) or</b></font> <font size="2" face="serif"><b>Indirect (I)</b></font></td>
<td width="9%" align="center"><font size="2" face="serif"><b>Nature of<br>
  Indirect</b></font><br>  <font size="2" face="serif"><b>Beneficial Ownership</b></font></td>
<td><div align="center"><font size="2" face="serif"><b>Disclaims</b></font><br>
      <font size="2" face="serif"><b>Pecuniary Interest</b></font></div></td>
</tr>
<tr valign="bottom">
<td align="left"><font size="2" face="serif">JPMP Master Fund Manager, L.P.<br>
  c/o J.P. Morgan Partners, LLC <br>
  1221 Avenue of the Americas - 40th Floor<br>
  New York, NY 10020</font></td>
<td align="center"><font size="2" face="serif">J.P. Morgan Partners (BHCA), L.P.</font></td>
<td align="center"><font size="2" face="serif">April 28, 2004</font></td>
<td align="center"><font size="2" face="serif">Barrier Therapeutics,
Inc. (&#147;BTRX&#148;)</font></td>
<td align="center"><font size="2" face="serif">See Table II Rows 1 and 6</font></td>
<td align="center"><font size="2" face="serif">See Table II Rows 1 and 6</font></td>
<td align="center"><font size="2" face="serif">I</font></td>
<td align="left"><font size="2" face="serif">See Explanatory Note 2 below</font></td>
<td align="center"><font size="2" face="serif">No</font></td>
</tr>
<tr valign="bottom">
<td align="left"><font size="2" face="serif">JPMP Capital Corp.<br>
  c/o J.P. Morgan Partners, LLC <br>
  1221 Avenue of the Americas - 40th Floor <br>
  New York, NY 10020</font></td>
<td align="center"><font size="2" face="serif">J.P. Morgan Partners (BHCA), L.P.</font></td>
<td align="center"><font size="2" face="serif">April 28, 2004</font></td>
<td align="center"><font size="2" face="serif">Barrier Therapeutics,
Inc. (&#147;BTRX&#148;)</font></td>
<td align="center"><font size="2" face="serif">See Table II</font></td>
<td align="center"><font size="2" face="serif">See Table II</font></td>
<td align="center"><font size="2" face="serif">I</font></td>
<td align="left"><font size="2" face="serif">See Explanatory<br>
Note 3 below</font></td>
<td align="center"><font size="2" face="serif">No</font></td>
</tr>
<tr valign="bottom">
  <td align="left"><font size="2" face="serif">J.P. Morgan Chase &amp; Co. <br>
    270 Park Avenue <br>
    35th Floor<br>
    New York, NY 10017</font></td>
  <td align="center"><font size="2" face="serif">J.P. Morgan Partners (BHCA),
    L.P.</font></td>
  <td align="center"><font size="2" face="serif">April 28, 2004</font></td>
  <td align="center"><font size="2" face="serif">Barrier Therapeutics,
Inc. (&#147;BTRX&#148;)</font></td>
  <td align="center"><font size="2" face="serif">See Table II</font></td>
  <td align="center"><font size="2" face="serif">See Table II</font></td>
  <td align="center"><font size="2" face="serif">I</font></td>
  <td align="left"><font size="2" face="serif">See Explanatory<br>
Note 4 below</font></td>
  <td align="center"><font size="2" face="serif">No</font></td>
</tr>
<tr valign="bottom">
  <td align="left"><font size="2" face="serif">J.P. Morgan Partners, Global Investors, L.P.<br>
    c/o J.P. Morgan Partners, LLC<br>
    1221 Avenue of the Americas-40th Floor<br>
    New York, New York 10020</font></td>
  <td align="center"><font size="2" face="serif">J.P. Morgan Partners (BHCA),
    L.P.</font></td>
  <td align="center"><font size="2" face="serif">April 28, 2004</font></td>
  <td align="center"><font size="2" face="serif">Barrier Therapeutics,
Inc. (&#147;BTRX&#148;)</font></td>
  <td align="center"><font size="2" face="serif">See Table II Rows 2 and 7</font></td>
  <td align="center"><font size="2" face="serif">See Table II Rows 2 and 7</font></td>
  <td align="center"><font size="2" face="serif">D</font></td>
  <td align="left"><font size="2" face="serif">See Explanatory<br>
Note 5 below</font></td>
  <td align="center">&nbsp;</td>
</tr>
<tr valign="bottom">
  <td align="left"><font size="2" face="serif">J.P. Morgan Partners, Global Investors (Cayman), L.P.<br>
    c/o J.P. Morgan Partners, LLC<br>
    1221 Avenue of the Americas-40th Floor<br>
    New York, New York 10020</font></td>
  <td align="center"><font size="2" face="serif">J.P. Morgan Partners (BHCA),
    L.P.</font></td>
  <td align="center"><font size="2" face="serif">April 28, 2004</font></td>
  <td align="center"><font size="2" face="serif">Barrier Therapeutics,
Inc. (&#147;BTRX&#148;)</font></td>
  <td align="center"><font size="2" face="serif">See Table II Rows 3 and 8</font></td>
  <td align="center"><font size="2" face="serif">See Table II Rows 3 and 8</font></td>
  <td align="center"><font size="2" face="serif">D</font></td>
  <td align="left"><font size="2" face="serif">See Explanatory<br>
Note 6 below</font></td>
  <td align="center">&nbsp;</td>
</tr>
<tr valign="bottom">
  <td align="left"><font size="2" face="serif">J.P. Morgan Partners, Global Investors A, L.P.<br>
    c/o J.P. Morgan Partners, LLC<br>
    1221 Avenue of the Americas-40th Floor<br>
    New York, New York 10020</font></td>
  <td align="center"><font size="2" face="serif">J.P. Morgan Partners (BHCA),
    L.P.</font></td>
  <td align="center"><font size="2" face="serif">April 28, 2004</font></td>
  <td align="center"><font size="2" face="serif">Barrier Therapeutics,
Inc. (&#147;BTRX&#148;)</font></td>
  <td align="center"><font size="2" face="serif">See Table II Rows 4 and 9</font></td>
  <td align="center"><font size="2" face="serif">See Table II Rows 4 and 9</font></td>
  <td align="center"><font size="2" face="serif">D</font></td>
  <td align="left"><font size="2" face="serif">See Explanatory<br>
Note 7 below</font></td>
  <td align="center">&nbsp;</td>
</tr>
<tr valign="bottom">
  <td align="left"><font size="2" face="serif">J.P. Morgan Partners, Global Investors
      (Cayman) II, L.P.<br>
    c/o J.P. Morgan Partners, LLC<br>
    1221 Avenue of the Americas-40th Floor<br>
    New York, New York 10020</font></td>
  <td align="center"><font size="2" face="serif">J.P. Morgan Partners (BHCA),
    L.P.</font></td>
  <td align="center"><font size="2" face="serif">April 28, 2004</font></td>
  <td align="center"><font size="2" face="serif">Barrier Therapeutics,
Inc. (&#147;BTRX&#148;)</font></td>
  <td align="center"><font size="2" face="serif">See Table II Rows 5 and 10</font></td>
  <td align="center"><font size="2" face="serif">See Table II Rows 5 and 10</font></td>
  <td align="center"><font size="2" face="serif">D</font></td>
  <td align="left"><font size="2" face="serif">See Explanatory<br>
Note 8 below</font></td>
  <td align="center">&nbsp;</td>
</tr>
<tr valign="bottom">
  <td align="left"><font size="2" face="serif">JPMP Global Investors, L.P.<br>
    c/o J.P. Morgan Partners, LLC<br>
    1221 Avenue of the Americas-40th Floor<br>
    New York, New York 10020</font></td>
  <td align="center"><font size="2" face="serif">J.P. Morgan Partners (BHCA),
    L.P.</font></td>
  <td align="center"><font size="2" face="serif">April 28, 2004</font></td>
  <td align="center"><font size="2" face="serif">Barrier Therapeutics,
Inc. (&#147;BTRX&#148;)</font></td>
  <td align="center"><font size="2" face="serif">See Table II Rows 2-5 and 7-10</font></td>
  <td align="center"><font size="2" face="serif">See Table II Rows 2-5 and 7-10</font></td>
  <td align="center"><font size="2" face="serif">I</font></td>
  <td align="left"><font size="2" face="serif">See Explanatory<br>
Note 9 below</font></td>
  <td align="center"><font size="2" face="serif">No</font></td>
</tr>
</table>
<p align="left"><font size="2" face="serif">Explanatory Note:</font></p>
<table width="100%" cellspacing="0" cellpadding="0" border="0">
<tr valign="top">
<td width="3%"><font size="2" face="serif">1)</font></td>
<td align="left"><font size="2" face="serif">The Designated Reporter is executing this report on behalf of
  all Reporting Persons, each of whom has authorized it to do so. Each of the
  Reporting Persons disclaims beneficial ownership of the Issuer&#146;s securities
  to the extent it exceeds such Person&#146;s pecuniary interest.</font></td>
</tr>
<tr valign="top">
  <td>&nbsp;</td>
  <td align="left">&nbsp;</td>
</tr>
</table>
<table width="100%" cellspacing="0" cellpadding="0" border="0">
<tr valign="top">
<td width="3%"><font size="2" face="serif">2)</font></td>
<td align="left"><font size="2" face="serif">The amounts shown in Table II in rows 1 and 6 represent the
  beneficial ownership of the Issuer&#146;s equity securities by J.P. Morgan Partners
  (BHCA), L.P. (&#147;JPM BHCA&#148;), a portion of which may be deemed attributable
  to the Reporting Person because it is the sole general partner of JPM BHCA.</font></td>
</tr>
<tr valign="top">
  <td>&nbsp;</td>
  <td align="left">&nbsp;</td>
</tr>
</table>
<table width="100%" cellspacing="0" cellpadding="0" border="0">
<tr valign="top">
<td width="3%"><font size="2" face="serif">3)</font></td>
<td align="left"><font size="2" face="serif">The amounts shown in Table II represent the beneficial ownership
  of the Issuer&#146;s equity securities by (a) JPM BHCA, and (b) J.P. Morgan
  Partners Global Investors, L.P., J.P. Morgan Partners Global Investors A, L.P.,
  J.P. Morgan Partners Global Investors (Cayman), L.P., and J.P. Morgan Partners
  Global Investors (Cayman) II, L.P. (the &#147;JPMP Global Entities&#148;),
  a portion of which may be deemed attributable to the Reporting Person because
  it is (1) the general partner of JPMP Master Fund Manager, L.P. (&#147;MF
  Manager&#148;), the sole general partner of JPM BHCA and (2) the general partner
  of JPMP Global Investors, L.P. which is the general partner of each of the
  JPMP Global Entities. The actual pro rata portion of such beneficial ownership
  that may be deemed to be attributable to the Reporting Person is not readily
  determinable because it is subject to several variables, including the internal
  rate of return and vesting of interests within JPM BHCA, MF Manager and each
  of the JPMP Global Entities.</font></td>
</tr>
<tr valign="top">
  <td>&nbsp;</td>
  <td align="left">&nbsp;</td>
</tr>
</table>
<table width="100%" cellspacing="0" cellpadding="0" border="0">
<tr valign="top">
<td width="3%"><font size="2" face="serif">4)</font></td>
<td align="left"><font size="2" face="serif">The amounts shown in Table II represent the beneficial ownership
  of the Issuer&#146;s equity securities by JPM BHCA and the JPMP Global Entities,
  a portion of which may be deemed attributable to the Reporting Person because
  it is the sole stockholder of JPMP Capital Corp. and of Chatham Ventures, Inc.,
  the limited partner of JPM BHCA. The actual pro rata portion of such beneficial
  ownership that may be attributable to the Reporting Person is not readily determinable
  because it is subject to several variables, including the internal rate of
  return and vesting of interests within JPM BHCA, MF Manager and the each of
  the JPMP Global Entities.</font></td>
</tr>
<tr valign="top">
  <td>&nbsp;</td>
  <td align="left">&nbsp;</td>
</tr>
<tr valign="top">
  <td><font size="2" face="serif">5)</font></td>
  <td align="left"><font size="2" face="serif">The amount shown represents the beneficial ownership of the
    Issuer&#146;s equity securities by J.P. Morgan Partners Global Investors,
    L.P.</font></td>
</tr>
<tr valign="top">
  <td>&nbsp;</td>
  <td align="left">&nbsp;</td>
</tr>
<tr valign="top">
  <td><font size="2" face="serif">6)</font></td>
  <td align="left"><font size="2" face="serif">The amount shown represents the beneficial ownership of the
    Issuer&#146;s equity securities by J.P. Morgan Partners Global Investors
    (Cayman), L.P.</font></td>
</tr>
<tr valign="top">
  <td>&nbsp;</td>
  <td align="left">&nbsp;</td>
</tr>
<tr valign="top">
  <td><font size="2" face="serif">7)</font></td>
  <td align="left"><font size="2" face="serif">The amount shown represents the beneficial ownership of the
    Issuer&#146;s equity securities by J.P. Morgan Partners Global Investors
    A, L.P.</font></td>
</tr>
<tr valign="top">
  <td>&nbsp;</td>
  <td align="left">&nbsp;</td>
</tr>
<tr valign="top">
  <td><font size="2" face="serif">8)</font></td>
  <td align="left"><font size="2" face="serif">The amount shown represents the beneficial ownership of the
    Issuer&#146;s equity securities by J.P. Morgan Partners Global Investors
    (Cayman) II, L.P.</font></td>
</tr>
<tr valign="top">
  <td>&nbsp;</td>
  <td align="left">&nbsp;</td>
</tr>
<tr valign="top">
  <td><font size="2" face="serif">9)</font></td>
  <td align="left"><font size="2" face="serif">The amounts shown in Table II in rows 2-5 and 7-10 represent
    the beneficial ownership of the Issuer&#146;s equity securities by the JPMP
    Global Entities. The Reporting Person is the general partner of each of the
    JPMP Global Entities.</font></td>
</tr>
</table>

<p>&nbsp;</p>
<hr noshade align="center" width="100%" size="2">
</body>
</html>

</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
